(Press-News.org) CHICAGO -- Researchers have found an association between excess body weight and an increased risk for cancer recurrence in men with clinically localized prostate cancer.
"Men diagnosed with early-stage prostate cancer and who have excess body weight as indicated by a higher-than-normal body mass index (BMI) have an increased risk for cancer recurrence after treatment," said Vincent L. Freeman, M.D., M.P.H., associate professor in the division of epidemiology and biostatistics in the School of Public Health at the University of Illinois in Chicago, Ill.
Freeman presented results of this cross-sectional study at the AACR Annual Meeting 2012, held here March 31 - April 4.
Freeman and colleagues examined BMI, which measures body weight relative to height, and risk for cancer recurrence based on blood prostate-specific antigen level, physical exam and prostate cancer biopsy results in 119 men who were awaiting surgery for clinically localized prostate cancer.
The results showed that the risk for cancer recurrence increased with increasing BMI. Men in the upper quartile for BMI were nearly eight times more likely to have prostate cancers that had a moderate-to-high risk for recurrence after treatment compared with men in the lower quartile. Men in the upper-middle and lower-middle quartiles for BMI were 6.5 times and 3.5 times more likely to have a moderate-to-high recurrence risk, respectively.
"The association was not limited to obese men; even being just overweight based on BMI was associated with an increased risk for prostate cancer recurrence," Freeman said.
He and his colleagues concluded that body weight status and related lifestyle factors connected to prostate cancer could be used as viable indicators for high-risk cases.
"The results provide additional support for a mechanistic link between body weight status and the clinical presentation and course of prostate cancer," Freeman said. "Our findings also highlight the importance of maintaining a healthy body weight throughout adulthood."
###The study was funded by the National Institutes of Health/National Cancer Institute.
Press registration for the AACR Annual Meeting 2012 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration.
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the AACR
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR's membership includes 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of individual and team science grants in cancer research that have the potential for patient benefit. The AACR actively communicates with legislators and policy makers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit http://www.AACR.org.
Presenter: Vincent L. Freeman, M.D., M.P.H.
Abstract Number: 4443
Title: Body weight status predicts pre-treatment risk of PSA failure in men with clinically localized prostate cancer
Author Block: Vincent L. Freeman1, Robert C. Flanigan2, Courtney M. Hollowell3, Jeffrey Branch4, Leslie Deane1, Marcus Quek2, Patricia P. Vidal3, Nicholas Friedman4, Daisy Cintron1, Firas Dabbous1, Linda Millbrandt2, Anne Garabedian4, Jasmine Cleofe3, Sandra L. Gomez1. 1Univ. of Illinois at Chicago, Chicago, IL; 2Loyola University Medical Center, Maywood, IL; 3John H. Stoger Hospital of Cook County, Chicago, IL; 4Edward Hines, Jr. VA Hospital, Hines, IL
Introduction and Objective: Obesity/excessive adiposity in men with clinically organ-confined prostate cancer is of growing concern, because it associates with an increased risk of cancer recurrence after definitive therapy based on post-treatment prognostic parameters. The objective of this study was to evaluate whether body weight status associates with pre-treatment predictors of cancer recurrence in this patient population.
Methods: We performed a cross-sectional study of body weight status and pre-treatment risk of PSA failure in 119 men awaiting radical prostatectomy for clinically localized prostate cancer in four urologic clinics in the Chicago area. Body weight status was assessed using the body mass index (BMI) and dual-energy x-ray absorptiometry (DXA). D'Amico risk scores, which are based on clinical tumor stage, biopsy Gleason sum, and pre-treatment PSA, were used to rank each patient's 5-year risk of PSA failure as low, intermediate, or high. Ordinal logistical regression analyzed the association between BMI quartile and D'Amico risk scores after accounting for age, race, total grams of body fat, and study site.
Results: The risk of PSA failure increased with increasing quartile of BMI. Relative to the lowest BMI quartile, the cumulative odds of an intermediate or higher D'Amico risk score vs. a low risk score (the "cumulative odds ratio") for patients in the second BMI quartile (mean BMI = 27.8 kg/m2) was 3.51 (95% CI = 1.07 to 11.5, p = .038). For patients in the third quartile (mean BMI = 32.0 kg/m2) and forth quartile (mean BMI = 37.0 kg/m2), the cumulative OR was 6.52 (95% CI = 1.72 to 24.6, p = .0057) and 7.74 (95% CI = 1.18 to 50.9, p = .033), respectively (OR trend = 1.98, 95% CI = 1.09 to 3.59, p = .0254).
Conclusions: Body weight status predicts pre-treatment risk of PSA failure in men with clinically localized prostate cancer. This provides further support for a mechanistic link between body weight status, which reflects energy balance, and prostate cancer prognosis. The results also highlight the potential for using body weight status and other lifestyle-related factors pertinent to prostate cancer to identify men who are at high risk for unfavorable treatment outcomes.
Excess body weight associated with increased risk for prostate cancer recurrence
2012-04-04
ELSE PRESS RELEASES FROM THIS DATE:
Noninvasive stool test for colorectal cancer unaffected by variables
2012-04-04
CHICAGO — Research on an investigational DNA methylation test for colorectal cancer demonstrated that the only clinical variable that influenced test results was age, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
"There was a progressive increase in background methylation levels that varied widely between methylation markers tested as a patient aged," said David Ahlquist, M.D., professor of medicine and a consultant in gastroenterology and hepatology at the Mayo Clinic in Rochester, Minn. "For example, median background ...
Caffeine and exercise may be protective against skin cancer caused by sun exposure
2012-04-04
CHICAGO — The combined effects of exercise plus caffeine consumption may be able to ward off skin cancer and also prevent inflammation related to other obesity-linked cancers.
"We found that this combination treatment can decrease sunlight-caused skin cancer formation in a mouse model," said Yao-Ping Lu, Ph.D., associate research professor of chemical biology and director of skin cancer prevention at the Rutgers Ernest Mario School of Pharmacy in Piscataway, N.J. He presented these findings at the AACR Annual Meeting 2012, held here March 31 - April 4.
"I believe we ...
Aerison Pty Ltd Supports Environmental Sustainability during Australia's Economic Boom, in Manufacturing Digital
2012-04-04
As the mining and resources industries fuel Australia's economic growth, companies such as Aerison Pty Ltd are working to lessen the impact of these projects on the environment.
Since 1993, Western Australia-based Aerison has completed over 700 environmental projects ranging from air pollution and dust control solutions at mine sites to VOC destruction technology implementation and acoustic noise control systems at various mechanical facilities. Though the company was originally known as HPS Environmental, then as Enerflex Environmental in 2005, and finally as Aerison ...
Race may play role in presentation of triple-negative breast cancer in hispanic women
2012-04-04
CHICAGO — Hispanic women in Puerto Rico who have triple-negative breast cancer share similar disease characteristics with Hispanic women in California, suggesting that race plays a significant role in the presentation of triple-negative breast cancer among Hispanic women.
These study results were presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
"We think the fact that our patients are geographically located outside the mainland and still have the same disease characteristics suggests that the biology of the disease plays a major role in how ...
Tswana Pride Overcomes Adversity and Operates as Botswana's Premier Poultry Producer, in Food & Drink Digital
2012-04-04
Tswana Pride has overcome incredible adversity in the last three years to become the largest poultry producing company in Botswana. In 2009, the company's abattoir burnt down and had to be entirely rebuilt at a cost of 90 million BWP. The new facility, which opened for operation in mid-2011, was constructed to the latest European standards and today it is Botswana's biggest, most state-of-the-art abattoir.
When the abattoir was destroyed by fire, Tswana Pride used the opportunity to build the most technologically sophisticated facility in the region. Although the company ...
Nearly half of cancer survivors died from conditions other than cancer
2012-04-04
CHICAGO -- Although cancer recurrence may be the overriding fear for many survivors, nearly half of survivors from a recently presented study died from other conditions.
These results indicate survivors could potentially benefit from a more comprehensive, less cancer-focused approach to their health, according to lead researcher Yi Ning, M.D., Sc.D., assistant professor in the department of epidemiology and community health at Virginia Commonwealth University (VCU) and associate research member at VCU Massey Cancer Center in Richmond, Va. Ning presented the results at ...
Drug combination may provide option to patients with NSCLC ineligible for bevacizumab
2012-04-04
CHICAGO — A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
"The combination of carboplatin and nab-paclitaxel demonstrates promising efficacy with tolerable toxicity in patients with non-small cell lung cancer (NSCLC) ineligible for therapy with bevacizumab," said Gregory A. Otterson, M.D., professor of internal medicine, co-director of the thoracic oncology ...
"Vampire Zoo": British Film is Collaborative Effort of Creative Team
2012-04-04
The trailer for a new British film reveals an edgy and sophisticated work of cinematography which will likely interest wide audiences in the United States as well as the UK. Stunning music, scenes, acting, and photography combine to make this a gem in the genre of independent films.
Vampire Zoo has been written as a 6 part TV series and also a feature film.
The creative team behind Vampire Zoo is comprised of a coalition of filmmakers - Clockwork Productions, JTMR Films and Foot in the Door Productions - who are attempting to raise the funds to make the project independently ...
Cruciferous vegetable consumption linked to improved breast cancer survival rates
2012-04-04
CHICAGO — Eating cruciferous vegetables after breast cancer diagnosis was associated with improved survival among Chinese women, according to results presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
"Breast cancer survivors can follow the general nutritional guidelines of eating vegetables daily and may consider increasing intake of cruciferous vegetables, such as greens, cabbage, cauliflower and broccoli, as part of a healthy diet," said Sarah J. Nechuta, M.P.H., Ph.D., a postdoctoral research fellow at Vanderbilt University in Nashville, Tenn.
She ...
Baseline hormone levels may predict survival in metastatic, castration-resistant prostate cancer
2012-04-04
CHICAGO — Patients with castration-resistant prostate cancer treated with the androgen inhibitor abiraterone and who had high baseline hormone levels had longer overall survival compared with patients with low hormone levels, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.
If confirmed, these data mean that levels of hormones, specifically adrenal androgens, may provide physicians with another way to predict the efficacy of therapy in patients with metastatic, castration-resistant prostate cancer, according to Charles J. Ryan, ...